GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » EnBio Holdings, Inc (TSE:6092) » Definitions » Revenue

EnBio Holdings, (TSE:6092) Revenue : 円8,335 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is EnBio Holdings, Revenue?

EnBio Holdings,'s revenue for the three months ended in Dec. 2023 was 円1,503 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円8,335 Mil. EnBio Holdings,'s Revenue per Share for the three months ended in Dec. 2023 was 円184.71. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円1,097.65.

Warning Sign:

EnBio Holdings, Inc revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of EnBio Holdings, was -13.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -2.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 11 years, EnBio Holdings,'s highest 3-Year average Revenue per Share Growth Rate was 46.40% per year. The lowest was -9.90% per year. And the median was 9.70% per year.


EnBio Holdings, Revenue Historical Data

The historical data trend for EnBio Holdings,'s Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EnBio Holdings, Revenue Chart

EnBio Holdings, Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,563.05 7,408.50 6,840.61 8,987.87 8,120.31

EnBio Holdings, Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,135.09 1,348.35 3,423.08 2,059.76 1,503.35

Competitive Comparison of EnBio Holdings,'s Revenue

For the Specialty Business Services subindustry, EnBio Holdings,'s Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EnBio Holdings,'s Revenue Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, EnBio Holdings,'s Revenue distribution charts can be found below:

* The bar in red indicates where EnBio Holdings,'s Revenue falls into.



EnBio Holdings, Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8,335 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EnBio Holdings,  (TSE:6092) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


EnBio Holdings, Revenue Related Terms

Thank you for viewing the detailed overview of EnBio Holdings,'s Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


EnBio Holdings, (TSE:6092) Business Description

Traded in Other Exchanges
N/A
Address
Tokyo Kandata cho 2-11 O-machi Takaku Building 3F, Chiyoda-ku, Tokyo, JPN
EnBio Holdings, Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.

EnBio Holdings, (TSE:6092) Headlines

No Headlines